Microglia are the resident immune cells of the central nervous system and play far more diverse roles than once thought. Traditionally viewed as brain macrophages that clear pathogens and debris, they are now recognized as key regulators of brain development, plasticity and disease.

During development, microglia sculpt neural circuits by pruning synapses, promoting the elimination of weak or unnecessary connections and supporting the maturation of functional networks. They respond dynamically to local neuronal activity and molecular signals, helping match connectivity to experience.

In the healthy adult brain, microglia constantly survey their environment with motile processes, clearing dead cells and protein aggregates, secreting growth factors, and maintaining homeostasis. They exist in a spectrum of states rather than a simple resting versus activated dichotomy, with their gene expression and behavior tuned to region, age and context.

In disease and injury, microglia can be both protective and harmful. They mount inflammatory responses that help contain damage and remove debris, but chronic or dysregulated activation contributes to neurodegeneration and cognitive decline. In conditions such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis, genetic variants that affect microglial function modify risk and progression, implicating them as central players rather than bystanders.

Current research is dissecting microglial subtypes, lineage origins and signaling pathways using single cell omics, advanced imaging and genetic tools. There is growing interest in targeting microglia to modulate inflammation, enhance debris clearance or support regeneration. However, because these cells are deeply integrated into normal brain function, therapeutic strategies must balance dampening harmful responses with preserving their essential homeostatic and developmental roles.